Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakshi Gulati

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Seminars in Cancer Biology|May 18, 2013
Cancer networks and beyond: interpreting mutations using the human interactome and protein structureSakshi Gulati, Tammy M K Cheng, Paul A Bates
The Lancet. Oncology|August 8, 2015
Relapse models for clear cell renal carcinomaSakshi Gulati, Samra Turajlic, James Larkin, et al.
Briefings in Functional Genomics|July 20, 2012
Understanding cancer mechanisms through network dynamicsTammy M K Cheng, Sakshi Gulati, Rudi Agius, et al.
European Urology|July 23, 2014
Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkersSakshi Gulati, Pierre Martinez, Tejal Joshi, et al.
Cancer Research Communications|October 11, 2023
Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell CarcinomaMaria Secrier, Lara McGrath, Felicia Ng, et al.
British Journal of Pharmacology|November 15, 2018
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeuticsAlice Lallo, Sakshi Gulati, Maximilian W Schenk, et al.
Scientific Reports|August 14, 2019
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancerSumitra Mohan, Mahmood Ayub, Dominic G Rothwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung CancerAlice Lallo, Kristopher K Frese, Christopher J Morrow, et al.
Cancer Research Communications|December 18, 2025
Characterisation of the immunogenomic landscape of ovarian cancer uncovers a distinct subset of endometroid tumours associated with high CST2 expression and a favourable prognosisJames Boyle, Jan Zaucha, Felicia Ng, et al.
Nature Genetics|February 4, 2014
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencingMarco Gerlinger, Stuart Horswell, James Larkin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Seminars in Cancer Biology|May 18, 2013
Cancer networks and beyond: interpreting mutations using the human interactome and protein structureSakshi Gulati, Tammy M K Cheng, Paul A Bates
The Lancet. Oncology|August 8, 2015
Relapse models for clear cell renal carcinomaSakshi Gulati, Samra Turajlic, James Larkin, et al.
Briefings in Functional Genomics|July 20, 2012
Understanding cancer mechanisms through network dynamicsTammy M K Cheng, Sakshi Gulati, Rudi Agius, et al.
European Urology|July 23, 2014
Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkersSakshi Gulati, Pierre Martinez, Tejal Joshi, et al.
Cancer Research Communications|October 11, 2023
Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell CarcinomaMaria Secrier, Lara McGrath, Felicia Ng, et al.
British Journal of Pharmacology|November 15, 2018
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeuticsAlice Lallo, Sakshi Gulati, Maximilian W Schenk, et al.
Scientific Reports|August 14, 2019
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancerSumitra Mohan, Mahmood Ayub, Dominic G Rothwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung CancerAlice Lallo, Kristopher K Frese, Christopher J Morrow, et al.
Cancer Research Communications|December 18, 2025
Characterisation of the immunogenomic landscape of ovarian cancer uncovers a distinct subset of endometroid tumours associated with high CST2 expression and a favourable prognosisJames Boyle, Jan Zaucha, Felicia Ng, et al.
Nature Genetics|February 4, 2014
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencingMarco Gerlinger, Stuart Horswell, James Larkin, et al.
Pageof 2